Professor John McGrath
Coordinating principal investigator
John McGrath received his medical degree from the University of Queensland. After working as a community-based psychiatrist, he moved into full-time research, becoming the Director of the Queensland Centre for Mental Health Research in 1990. He holds appointments at The University of Queensland Department of Psychiatry and the Queensland Brain Institute.
His research aims to generate and evaluate nongenetic risk factors for schizophrenia. He has forged productive cross-disciplinary collaborations linking risk factor epidemiology with developmental neurobiology (e.g. using animal models to explore candidate exposures). In addition, he has supervised major systematic reviews of the incidence, prevalence and mortality of schizophrenia.
He has won several national and international awards including the Premier's Award for Medical Research, a Queensland-Smithsonian Fellowship, a Rockefeller Foundation Bellagio Residency, the Organon Senior Research Award, and the Founders’ Medal from the Australasian Society for Psychiatric Research. The Australian government awarded John a Centenary Medal in 2003 and in 2007 he was appointed a Member of the Order of Australia (AM). He is an Associate Editor for Schizophrenia Bulletin, and is on the editorial boards of several international journals. He has published over 250 peer-reviewed articles.
Associate Professor James Scott
James is a child and adolescent psychiatrist whose main focus of research is broadly encapsulated under (i) child and adolescent mental health and (ii) early psychosis.
He has extensive clinical and research experience in areas of child and adolescent mental health including depression, anxiety, aggression, self harm, developmental disorders and pharmacotherapy. His research interests in early psychosis are prevention, phenomenology and treatment options.
James is currently engaged in a programme of research examining psychotic-like experiences in otherwise healthy individuals, mental health outcomes of bullying in adolescents, the role of cytokines in adolescent depression, the outcomes of early intervention in young children with autism and the outcomes of adolescents experiencing their first episode of psychosis.
The programmes are a combination of clinical work with patient samples and epidemiological studies in collaboration with large mental health surveys and birth cohort studies.
Andrea Baker is a clinical nurse consultant and is currently the study coordinator for the CADENCE-BZ clinical trial. She has completed her Masters in Mental Health and a Postgraduate Diploma in Community Health. Andrea has worked in health for 27 years, gaining clinical expertise in a variety of areas including mental health.
More recently Andrea has developed clinical expertise in research. For example she coordinated a high profile national schizophrenia research study (Survey of High Impact Psychosis - SHIP) in 2010 under the supervision of Professor John McGrath, which lead to further coordinating positions within Queensland Centre for Mental Health Research. Andrea has experience in supervision, support and coordination of staff and is proficient in Good Clinical Research Practice.